These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24295603)

  • 1. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study.
    Guo YJ; Chang MH; Chen PL; Lee YS; Chang YC; Liao YC
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e249-54. PubMed ID: 24295603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke.
    Rosenberg J; Do D; Cucchiara B; Messé SR
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
    Schutgens RE; Beckers MM; Haas FJ; Biesma DH
    Haematologica; 2005 Feb; 90(2):214-9. PubMed ID: 15710574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
    Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
    Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
    Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
    Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and mechanism of ischemic stroke associated with malignancy: a retrospective series.
    Álvarez-Pérez FJ; Verde I; Usón-Martín M; Figuerola-Roig A; Ballabriga-Planas J; Espino-Ibañez A
    Eur Neurol; 2012; 68(4):209-13. PubMed ID: 23018798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
    Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
    Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma D-dimer is a marker of deep vein thrombosis in acute stroke.
    Kuwashiro T; Toyoda K; Oyama N; Kawase K; Okazaki S; Nagano K; Koga M; Matsuo H; Naritomi H; Minematsu K
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):205-9. PubMed ID: 20813546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimers predict stroke subtype when assessed early.
    Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
    Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism.
    Tardy B; Tardy-Poncet B; Viallon A; Lafond P; Page Y; Venet C; Bertrand JC
    Thromb Haemost; 1998 Jan; 79(1):38-41. PubMed ID: 9459319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and transient ischaemic attack.
    Swartz JE; Jacobson BF; Connor MD; Bernstein PL; Fritz VU
    S Afr Med J; 2005 Aug; 95(8):607-12. PubMed ID: 16201006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
    Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
    Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification.
    Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Pollak ES; Kasner SE
    J Stroke Cerebrovasc Dis; 2009; 18(5):367-73. PubMed ID: 19717021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
    Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
    Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients.
    Guo L; Wang L; Liu W
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer levels and cerebral infarction in critically ill cancer patients.
    Ryu JA; Bang OY; Lee GH
    BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer is not a long-term prognostic marker following acute cerebral ischemia.
    Squizzato A; Ageno W; Finazzi S; Mera V; Romualdi E; Bossi A; Venco A
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):303-6. PubMed ID: 16651873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
    Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
    PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes.
    Paneesha S; Cheyne E; French K; Bacchu S; Borg A; Rose P
    Br J Haematol; 2006 Oct; 135(1):85-90. PubMed ID: 16925794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.